SEC-sourced researchBeta
BICX
BioCorRx Inc.
Company comparison ↗
Data passport
- CIK
- 0001443863
- Exchange
- OTC
- Business activity
- Services-Specialty Outpatient Facilities, NEC · SIC 8093
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 7,665.0000 | Mar 31, 2026 |
| December 2025 | 797,244.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 797,244.0000 | -3,440,146.0000 | -2,298,291.0000 | 2,147,212.0000 | 13,674,200.0000 | Mar 31, 2026 |
| December 2024 | 7,665.0000 | -5,106,124.0000 | -1,096,254.0000 | 385,941.0000 | 12,741,173.0000 | Mar 31, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
40/100
Profitability0
Growth100
Balance sheet0
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $797.24K | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenues | $7.67K | Jan 1, 2024 – Dec 31, 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$3.44M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$2.3M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $2.15M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $13.67M | Dec 31, 2025 | Mar 31, 2026 | 10-K |